Howe, J.G.
Hill, R.S.
Stroncek, J.D.
Shaul, J.L.
Favell, D.
Cheng, R.R. http://orcid.org/0000-0002-6003-3635
Engelke, K.
Genant, H.K.
Lee, D.C.
Keaveny, T.M.
Bouxsein, M.L.
Huber, B.
Article History
Received: 10 May 2019
Accepted: 7 November 2019
First Online: 4 December 2019
Compliance with ethical standards
:
: JGH is the founder and a shareholder of AgNovos. RSH, JDS, JLS, DF, and RRC are/were employees and shareholders of AgNovos. HKG has received honoraria, consulting fees, and speaker fees from AgNovos, Medtronic, Regeneron, BioMarin, Clementia, Amgen, Lilly, Daiichi, AstraZeneca, and MedImmune. MB has received consulting fees from AgNovos and research funding from Radius and Amgen. DCL is an employee of and has equity interest in O.N. Diagnostics. TMK is the founder, shareholder, and consulting Chief Science Officer of O.N. Diagnostics and has received consulting fees from AgNovos, O.N. Diagnostics, and Amgen. BH has received consulting fees from and is a shareholder of AgNovos.
: The study was IRB-approved by the Western Institutional Review Board and all subjects provided written informed consent.